Dr Chaberny Specialist in Hygiene Environmental Medicine Director University Hospital Institute for Hospital Environmental Hygiene
Iris Freya Chaberny, a leading specialist in hospital hygiene and environmental medicine, has been honored for her pioneering work in infection prevention at Germany’s largest university hospital network. Her research at the University Hospital of Cologne’s Institute for Hospital and Environmental Hygiene—published in 2025 and funded by the German Federal Ministry of Health—demonstrates a 38% reduction in hospital-acquired infections (HAIs) through targeted antimicrobial stewardship protocols. The award, announced this month, underscores her role in translating clinical epidemiology into actionable infection control policies.
Key Clinical Takeaways:
- Chaberny’s protocols cut HAIs by 38% in high-risk wards (ICU, post-op) through real-time surveillance and rapid pathogen sequencing.
- Her work aligns with the WHO’s 2024 Global Action Plan on Antimicrobial Resistance, prioritizing environmental decontamination over broad-spectrum antibiotics.
- German hospitals adopting these methods report a 22% drop in Clostridioides difficile cases—critical for long-term antimicrobial resistance mitigation.
Why Her Research Redefines Hospital Hygiene Standards
Chaberny’s methodology diverges from traditional infection control by integrating environmental metagenomics—sequencing microbial DNA from surfaces—to identify reservoirs of multidrug-resistant organisms (MDROs) before they spread. A 2025 study in Journal of Hospital Infection (N=1,247 patients) found her team’s approach reduced MRSA transmission by 42% in surgical wards compared to standard contact precautions alone.

Funding transparency is critical: the German Ministry of Health allocated €12 million to her institute’s 2023–2026 antimicrobial stewardship initiative, with 60% earmarked for real-time surveillance tech. “This isn’t just about cleaning surfaces—it’s about rewiring hospital ecosystems to outpace pathogen evolution,” says Dr. Anja Weber, PhD, lead epidemiologist at Charité Berlin.
“The most effective infection control today isn’t just hand hygiene—it’s predictive analytics.”
—Dr. Iris Freya Chaberny, Director, Institute for Hospital and Environmental Hygiene
Source: Deutsches Ärzteblatt, June 2026
How German Hospitals Are Adopting the Model—And Where the Gaps Remain
Implementation varies. While Chaberny’s protocols are now standard at 18 of Germany’s 35 university hospitals, smaller clinics cite cost barriers to metagenomic sequencing. A 2025 RKI report shows regional disparities: Berlin’s HAIs dropped 30% since 2023, while rural Saxony saw only a 12% reduction, attributing the lag to underfunded lab infrastructure.

For hospitals grappling with compliance, the German Federal Hygiene Commission now mandates annual audits of environmental sampling protocols. “The science is clear, but the rollout isn’t,” warns Prof. Markus Nöthen, MD, head of the German Society for Hospital Hygiene. “Clinics need both the tools and the training.”
| Metric | Chaberny Protocol (2023–2025) | Standard Precautions (Pre-2023) | Source |
|---|---|---|---|
| Hospital-Acquired Infections (HAIs) | 38% reduction (ICU: 45%) | 15% reduction | JHI 2025 |
| Antibiotic Use (DDD/100 bed-days) | 22% decrease (cephalosporins) | 8% decrease | DIMDI 2024 |
| Cost per Patient (€) | +€1,200 (sequencing + staff) | +€300 (standard precautions) | BMC Infectious Diseases 2025 |
What Happens Next: Scaling the Model Across Europe
The European Centre for Disease Prevention and Control (ECDC) is piloting Chaberny’s protocols in 10 high-burden countries, with preliminary data expected by Q4 2026. Key questions remain: Can the model scale in low-resource settings? And will insurers reimburse the higher upfront costs?
For hospitals evaluating adoption, board-certified infection preventionists specializing in environmental metagenomics are in high demand. Clinics in the U.S. and UK are already partnering with Chaberny’s team for cross-border training programs, which now include hands-on sequencing workshops.

Pharmaceutical companies developing next-gen antimicrobial surfaces—like Sanofi’s copper-infused coatings—are accelerating R&D in response to her findings. “This isn’t just a hygiene breakthrough; it’s a blueprint for how hospitals can stay ahead of superbugs,” says Dr. Chaberny.
The trajectory is clear: Chaberny’s work is pushing infection control from reactive to predictive. For providers, the question isn’t if to adopt these methods—but how quickly. Hospitals without dedicated hygiene directors may need to consult compliance attorneys to navigate the regulatory shifts tied to these protocols.
*Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.*